重症肺炎患者肺泡灌洗液中鲍曼不动杆菌检出情况及多重耐药性分析.pdfVIP

临床研究2025年12月第33卷第12期159

DOI:10.1038/s41572-020-00240-3.预后的研究[D].济南:山东大学,2024.

[2]ZHANGW,ZHANGBX,CHENXP.Adjuvant[9]KIRYUS,AKAIH,NOJIMAM,etal.Impactofhepatocellular

treatmentstrategyaftercurativeresectionforhepatocellularcarcinomaheterogeneityoncomputedtomographyas

carcinoma[J].FrontMed,2021,15(2):155-169.aprognosticindicator[J].SciRep,2017,7(1):12689.

DOI:10.1007/s11684-021-0848-3.DOI:10.1038/s41598-017-12688-7.

[3]陈一帆,游华,魏丽.中晚期原发性肝细胞癌现状及预后模型的[10]中国抗癌协会肝癌专业委员会.中国肿瘤整合诊治

研究进展[J].癌症进展,2024,22(12):1291-1296.指南(CACA)-肝癌部分[J].肿瘤综合治疗电子杂

[4]中华人民共和国国家卫生健康委员会医政医管局.原志,2022,8(3):31-63.

发性肝癌诊疗指南(2022年版)[J].中华消化外科杂[11]KRAJL,CHMIELP,GRYZIAKM,etal.Impactof

志,2022,21(2):143-168.thrombocytopeniaonsurvivalinpatientswithhepatocellular

[5]LENCIONIR,LLOVETJM.ModifiedRECIST(mRECIST)carcinoma:updatedmeta-analysisandsystematicreview[J].

assessmentforhepatocellularcarcinoma[J].SeminLiverCancers,2024,16(7):1293.DOI:10.3390/cancer

Dis,2010,30(1):52-60.DOI:10.1055/s-0030-1247132.[12]LULB,SUZM,ZHENGPC,etal.Associationbetweenplatelet

[6]NINOMIYAM,TSURUOKAM,INOUEJ,etal.Anewcountandhepatocellularcarcinomaoverallsurvival:alarge

modeltoestimatedurationofsurvivalinpatientswithretrospectivecohortstudy[J].BMJOpen,2020,10(11):e038172.

hepatocellularcarcinomawithBCLCintermediatestage[J].SciDOI:10.1136/bmjopen-2020-038172.

Rep,2023,13(1):20